NCT02972268View on ClinicalTrials.gov

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

PHASE3CompletedINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

November 2, 2017

Study Completion Date

August 14, 2018

Conditions
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin 0.2mg + Solifenacin 5mg

Tamsulosin 0.2mg + Solifenacin 5mg for 12wks

DRUG

Tamsulosin 0.2mg + Placebo(Solifenacin)

Tamsulosin 0.2mg + Placebo(Solifenacin) for 12wks

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY